Physician profile
Michael Henderson
NPI 1518166354
$1,812.58
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $183 · 2021: $431 · 2022: $469 · 2023: $205 · 2024: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $440.74 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $308.31 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $252.43 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $171.44 | 2021-2022 | |
| Boston Scientific Corporation | $109.88 | 2021-2022 | |
| Abbott Laboratories | $103.59 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.33 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $82.32 | 2019-2023 | Camzyos |
| Sanofi-Aventis U.S. LLC | $42.63 | 2019-2023 | |
| Vital Connect, INC | $42.00 | 2023 | Vitalpatch Rtm |
| Astrazeneca Pharmaceuticals Lp | $30.80 | 2019-2023 | Brilinta |
| Philips North America LLC | $30.40 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $27.25 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $24.44 | 2021 | |
| Abiomed | $15.40 | 2024 | Impella |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $14.97 | 2024 | |
| Pfizer INC. | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.